We are live on ! Find out more
RPRX icon

Repros Therapeutics
RPRX

Delisted

RPRX was delisted on the 31st of January, 2018.

81 hedge funds and large institutions have $414M invested in Repros Therapeutics in 2013 Q2 according to their latest regulatory filings, with 81 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

97.69% more ownership

Funds ownership: 0% → 97.69% (+98%)

23% less call options, than puts

Call options by funds: $35.1M | Put options by funds: $45.3M

Holders
81
Holders Change
+81
Holders Change %
–
% of All Funds
2.63%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
81
Increased
–
Reduced
–
Closed
–
Calls
$35.1​M
Puts
$45.3​M
Net Calls
-⁠$10.2​M
Net Calls Change
-⁠$10.2​M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter

RPRX Hedge Fund Activity: Q2 2013 in Review

81 of the 3,075 institutional investors tracked by Wall St. Rank reported a position in Repros Therapeutics (RPRX) for Q2 2013, worth a combined $414M.

Buyers outnumbered sellers: 81 funds opened new RPRX positions and 0 closed out — a net gain of 81 holders — while 0 added to existing stakes and 0 trimmed.

  • 81 institutional investors held Repros Therapeutics (RPRX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $414M of Repros Therapeutics stock for Q2 2013.
  • 81 funds opened new Repros Therapeutics positions in Q2 2013 and 0 closed out, a net change of +81 holders.

Based on aggregated 13F filings for Q2 2013.